New York S 6422: Relates to prescription labels for gonadotropin-releasing hormone agonists, pubertal suppressants, anabolic steroids, alpha reductase inhibitors, progestins, or drug classes for hormone replacement therapy

Status: REFERRED TO HIGHER EDUCATION (as of 2025-03-13)

State: New York · Session: 2025-2026 · Bill: S 6422

Sponsors: Brad Hoylman-Sigal, Jeremy Cooney

View New York S 6422 on LegisTrack → — full text, sponsors, votes, campaign finance, and cross-state matches.